Replies to post #1965 on Cytodyn Inc (CYDY)

[misiu143]

What I know , if for example patient will die ( God forbid , and if they not sure why patient died ) , they may hold study until they investigate.
Otherwise everything depends what results show , as for improvement , and side effects. We already know , they see no serious side effects here.
IMO, all is good .

[Amatuer17]

The rejection of drug can come based on - very bad adverse side effects (death being most severe or lack of efficacy at required level (see recent rejection of sarepta DMD drug)

Even in case of efficacy - the target audience maybe limited to smaller group or approved with black box warning.

Pro-140 has shown to be non toxic but and is relevant for CCT5 patients - it has shown good efficacy results in current trials so if it shows existing results in P3 it is likely to get approved.

The big question will be what is the %age patients get full results.

[scottsmith]

Exactly. Looks too good to be true is precisely how I described cydy to someone. Of course I've been a buyer anyway.